Cargando…
Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184954/ https://www.ncbi.nlm.nih.gov/pubmed/37198023 http://dx.doi.org/10.1016/j.vaccine.2023.05.008 |
| _version_ | 1785042246962249728 |
|---|---|
| author | Sun, Wellington |
| author_facet | Sun, Wellington |
| author_sort | Sun, Wellington |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10184954 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101849542023-05-16 Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective Sun, Wellington Vaccine Commentary Elsevier Ltd. 2023-06-07 2023-05-15 /pmc/articles/PMC10184954/ /pubmed/37198023 http://dx.doi.org/10.1016/j.vaccine.2023.05.008 Text en © 2023 Elsevier Ltd. All rights reserved. Elsevier has created a Monkeypox Information Center (https://www.elsevier.com/connect/monkeypox-information-center) in response to the declared public health emergency of international concern, with free information in English on the monkeypox virus. The Monkeypox Information Center is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its monkeypox related research that is available on the Monkeypox Information Center - including this research content - immediately available in publicly funded repositories, with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the Monkeypox Information Center remains active. |
| spellingShingle | Commentary Sun, Wellington Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective |
| title | Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective |
| title_full | Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective |
| title_fullStr | Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective |
| title_full_unstemmed | Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective |
| title_short | Monkeypox, smallpox, FDA, and accelerated approval of vaccines – A regulatory perspective |
| title_sort | monkeypox, smallpox, fda, and accelerated approval of vaccines – a regulatory perspective |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184954/ https://www.ncbi.nlm.nih.gov/pubmed/37198023 http://dx.doi.org/10.1016/j.vaccine.2023.05.008 |
| work_keys_str_mv | AT sunwellington monkeypoxsmallpoxfdaandacceleratedapprovalofvaccinesaregulatoryperspective |